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significantly different. This assessment was possible in all 
investigated muscles of young male volunteers, but less 
so in muscles of the other subjects due to lower signal-to-
noise ratio. Improvements for future studies are discussed. 
In vivo 13C MRSI after 13C–Cr ingestion is demonstrated 
for longitudinal studies of Cr uptake, turnover, and PCr/
TCr ratios of individual muscles in one exam.
Keywords Creatine · MR spectroscopy · 13C · Human 
muscle
Introduction
Creatine (Cr) occurs in fish and meat and is endogenously 
produced in the liver and kidneys (Guthmiller et al. 1994). 
It is taken up from blood vessels into tissues with high 
energy demands such as muscle and brain (Wyss and Kad-
durah-Daouk 2000). This uptake is facilitated by a creatine 
transporter protein (CrT), which transports the compound 
together with sodium into the cell against a Cr concentra-
tion gradient (Guerrero-Ontiveros and Wallimann 1998). 
Inside the cell, Cr is reversibly phosphorylated to phospho-
creatine (PCr) in the creatine kinase (CK) reaction. This 
Cr–PCr system plays a key role in energy metabolism as a 
temporal energy buffer and by facilitating substrate diffu-
sion (Meyer et al. 1984). A spontaneous reaction irrevers-
ibly degrades both Cr and PCr into creatinine, which is 
excreted via the kidneys (Wallimann et al. 2011; Hoberman 
et al. 1948). Because of low PCr levels in some dystrophic 
muscles (Kemp et al. 1993) and potential cellular protec-
tive effects (Pulido et al. 1998), Cr supplementation has 
been proposed as treatment for several neuromuscular dis-
orders (Kley et al. 2013). Cr is also recognized as an effec-
tive nutritional supplement in other diseases and in sports 
Abstract Creatine (Cr) supplementation to enhance mus-
cle performance shows variable responses among individu-
als and different muscles. Direct monitoring of the supplied 
Cr in muscles would address these differences. In this feasi-
bility study, we introduce in vivo 3D 13C MR spectroscopic 
imaging (MRSI) of the leg with oral ingestion of 13C4–cre-
atine to observe simultaneously Cr and phosphocreatine 
(PCr) for assessing Cr uptake, turnover, and the ratio PCr 
over total Cr (TCr) in individual muscles. 13C MRSI was 
performed of five muscles in the posterior thigh in seven 
subjects (two males and two females of ~20 years, one 
82-year-old male, and two neuromuscular patients) with 
a 1H/13C coil in a 3T MR system before, during and after 
intake of 15 % 13C4-enriched Cr. Subjects ingested 20 g 
Cr/day for 4 days in four 5 g doses at equal time intervals. 
The PCr/TCr did not vary significantly during supplemen-
tation and was similar for all subjects and investigated mus-
cles (average 0.71 ± 0.07), except for the adductor mag-
nus (0.64 ± 0.03). The average Cr turnover rate, assessed 
in male muscles, was 2.1 ± 0.7 %/day. The linear uptake 
rates of Cr were variable between muscles, although not 
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(Wyss and Schulze 2002; Gualano et al. 2012; Kley et al. 
2013).
However, selection of an effective Cr loading protocol 
is hampered by a wide variation in responsiveness between 
individuals (Harris et al. 1992; Greenhaff et al. 1994). This 
may be due to various factors determining Cr uptake, such 
as intracellular Cr concentration, hormone status, and fiber 
type composition (Mesa et al. 2002; Snow and Murphy 
2003). Moreover, the contribution of each factor may vary 
between different muscles and may change with age or due 
to disease (Coggan et al. 1992; Kreis et al. 1999; Dubowitz 
and Sewry 2007; McCall and Persky 2007). Therefore, an 
in vivo method to directly monitor the supplied Cr in indi-
vidual muscles would be desirable to help to understand 
and optimize Cr loading.
Magnetic resonance spectroscopy (MRS) has the unique 
capability to measure Cr and PCr levels in human tissues 
non-invasively. With proton (1H) MRS, the total amount of 
Cr (TCr) in muscles can be observed, and with phosphorus 
(31P) MRS, it is possible to monitor PCr (De Graaf 2007). 
Both 1H and 31P MRS have been used in studies of TCr 
and PCr levels in skeletal muscle after Cr supplementation 
and revealed differential Cr increases ranging from about 
5 % in the gastrocnemius to about 23 % in the quadriceps 
femoris (Vandenberghe et al. 1997; Kreis et al. 1999; Smith 
et al. 1998, 1999). To examine these two compounds indi-
vidually in one exam are complicated as different hardware 
is required for each nucleus and quantitative sequential 
measurements are hampered by the required calibrations 
(Brault et al. 2007). By carbon (13C) MRS, it is possible 
to observe separate signals for Cr and PCr simultaneously 
in skeletal muscle spectra, but because of the low natural 
abundance of 13C in the body, this is not a very sensitive 
method. However, with oral ingestion of 13C-4 labeled Cr, 
the signal-to-noise ratio can be increased. This was used 
to establish the PCr/TCr ratio and Cr turnover in the calf 
of a single individual only employing a surface coil adja-
cent to the calf for localization, mainly acquiring signal 
from the gastrocnemius (Kan et al. 2006). Multiple spa-
tially resolved MR spectra can be acquired with MR spec-
troscopic imaging (MRSI) and, therefore, allow the detec-
tion of metabolites in individual muscles (Vermathen et al. 
2012). Human muscles have not been assessed yet by 13C 
MRSI to monitor compounds labeled with 13C spins at 
thermal equilibrium.
The aim of the work described in this paper was to 
investigate the performance of three-dimensional 13C MRSI 
at 3T of the posterior thigh during and after the ingestion 
of 13C-4 labeled Cr. In particular, we wanted to know for 
different muscles what the PCr/TCr ratio is and how fea-
sible it is to measure Cr turnover and uptake, all in one 
examination. To test this feasibility of the method for clini-
cal research, we examined a variety of seven volunteers 
representing potentially different leg muscle conditions, 




For this feasibility study, we included four healthy young 
volunteers (YH), one 82-year-old male (OH), and two 
genetically confirmed FSHD patients. We made sure that 
participants had no MR contraindication (pacemaker, metal 
implants or claustrophobia). None of the subjects per-
formed sports at a professional level, were vegetarian, or 
were taking Cr as supplement.
Participants’ demographics are listed in Table 1. Ethi-
cal approval was obtained through the institutional review 
board, and written informed consent was obtained from all 
participants.
Study design
Participants ingested 20 g Cr per day for 4 days in four 5 g 
doses (15 % 13C enriched at the guanidino carbon, 13C-4–
Cr) at equally spaced intervals through the day. They were 
instructed to dilute the Cr in a glass of lukewarm water and 
to drink it along with 250 ml of standard carbohydrate solu-
tion to augment skeletal muscle Cr accumulation (Green 
et al. 1996).
After the first MR measurement on day 0, the participant 
was provided with 16 portions of the 13C-enriched Cr, and 
was instructed to start the Cr supplementation the next day.
The full study design consisted of 12 MR measurements 
at day 0, 1, 2, 3, 4, 5, 7, 12 ± 1, 14 ± 1, 19 ± 2, 41 ± 3, 
78 ± 3, and 105 ± 3. Day 0 was the baseline measure-
ment, days 1–4 were during Cr supplementation, and the 
remaining measurements were after Cr supplementation. 
The measurement protocol was reduced to six MR exams 
Table 1  Participants demographics
Fat fractions were similar between young healthy man and women 
(1.2 ± 0.3 % vs. 2.8 ± 0.8, p = 0.08 two-tailed t test)
Age (years) BMI (kg/m2) Weight (kg) Gender
Young healthy #1 23 20.94 57 Female
Young healthy #2 21 20.62 58 Male
Young healthy #3 21 22.06 63 Female
Young healthy #4 21 21.90 85 Male
Old healthy 82 30.67 95 Male
FSHD #1 72 33.46 90 Female
FSHD #2 41 24.68 73 Male
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for the older and FSHD subjects; one before Cr supplemen-
tation (day 0), two during (days 2 and 5), and three after 
(days 19, 41, and 78) Cr supplementation.
Blood and urine samples were taken on days 0, 3, and 
7 to monitor kidney function during Cr supplementation. 
Venous blood was drawn directly into a K2-EDTA vacuum 
tube. Tubes were centrifuged at 3000 revolutions per min-
ute for 10 min, and subsequently, the plasma was separated 
from the packed red blood cells and was stored at −80 °C 
until analysis. Cr and 13C-4–Cr concentrations were deter-
mined with mass spectroscopy.
MR protocol
MR exams were performed on a clinical 3Tesla MRI sys-
tem (Tim Trio, Siemens, Erlangen, Germany) with a 1H 
birdcage volume coil (diameter 25 cm) and a circularly 
polarized 13C half-volume coil (13 × 15 cm) inserted into 
the 1H coil. A fish oil capsule served as a matching land-
mark between the MR exams and was positioned at one-
third the distance between the anterior superior iliac spine 
and the patella. Subjects were placed feet first supine inside 
the magnet bore, and the coil was placed around the right 
upper leg. After scout imaging, the protocol consisted of T2 
multi-spin-echo imaging (T2-MRI; Kan et al. 2009) (field 
of view 175 × 175 mm, voxel size 0.68 × 0.68 mm repeti-
tion time (TR) 3000 ms, 16 equally spaces echo times (TE) 
7.7–123.2 ms, 8 slices, slice thickness/gap 6/9 mm).
Followed by 3D, 13C MRSI with an adiabatic BIR45 
excitation pulse centered at 157 ppm, which is between 
the resonance frequencies of Cr and PCr. The FOV was 
200 × 200 × 400 mm, and the matrix size was 10 × 10 × 8, 
resulting in nominal voxels of 20 × 20 × 50 mm. Further-
more, Hamming-weighted k-space acquisition was applied 
with TR 1000 ms, bandwidth 10 kHz, vector size 1024, 
and 30 averages with WALTZ16 proton decoupling during 
acquisition.
In one subject, a T1 measurement was performed at day 
10, by acquiring 13C free induction decays (with adiabatic 
excitation and 150 averages) at different repetition times 
(TR = 0.75, 1, 2, 3, and 8 s).
Because of the 13C coil sensitivity profile only spectra 
from the posterior thigh muscles, more specifically, the 
biceps femoris (BF), semimembranosus (SM), semitendi-
nosus (ST), adductor magnus (AM), and the gracilis (G) 
were collected (Fig. 1). The entire MR examination took 
about 1 h, including subject placement. All MRSI data sets 
were saved as raw files for off line processing.
Data analyses
Muscle specific fat-fractions were determined by fitting 
the signal of the multi-spin-echo images to a biexponential 
function with fixed relaxation times for fat and water as 
described previously (Kan et al. 2009), classifying severe 
fatty infiltration as a fat fraction above 80 % and minor as 
below 20 %.
For the 13C MRSI data, the matrix dimension was zero-
filled to 16 × 16 × 8. A spatial 100 % Hamming filter was 
applied to the 13C MRSI k-space data before voxel selec-
tion. From every slice in the field of view of the 13C coil, 
one voxel was selected per muscle using the program 
3DiCSI (Zhao et al. 2005). To position the voxel in the 
center of the muscle, grid-shifting was applied. Only voxels 
were selected that were completely lying within one mus-
cle, resulting in three voxels per muscle on average. The 
corresponding free induction decays (FID) were exported 
to jMRUI 4.0 for spectral fitting (Naressi et al. 2001).
Spectral fitting
Voxels from the same muscle were summed, subsequently, 
unwanted lipid resonances were removed from the 13C 
spectra with an HLSVD filter (Pijnappel et al. 1992), and 
the spectra were apodized by 10 Hz. From unlocalized 
high SNR MR spectra, a line width ratio of 0.81 and a 
Fig. 1  13C MRSI grid with voxels overlaid on T2-weighted MR 
image of the right thigh of a healthy young male after 4 days of cre-
atine supplementation. Because of the k space sampling, the true 
voxel shape is more a sphere, which is approached in the image by a 
red circle. The 13C half-volume coil, positioned adjacent to the ham-
string muscles, is indicated. The spectra are zoomed on the creatine 
signals. The muscles that are in the field of view of the coil include 
the biceps femoris (BF), semi-tendinosus (ST), semi-membranosus 
(SM), gracilis (G), and adductor magnus (AM), as delineated in the 
image (color figure online)
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frequency difference of 30 Hz between Cr (157.5 ppm) 
and PCr (156.6 ppm) were obtained as prior knowledge 
that was used in the fit of the signals to Gaussian line 
shapes using AMARES software (Vanhamme et al. 1997). 
With the Cr and PCr pools in equilibrium (Brault and 
Terjung 2003), the summed signal intensities of Cr and 
PCr served as TCr. Spectral quality was assessed by com-
paring the TCr signal intensity to the standard deviation 
(SD) of the noise (defined as SD of the last 10 % of the 
FID). Only spectra in which the TCr signal intensity was 
larger than the SD of the noise were included for further 
analysis. In addition, we excluded spectra in which the fit-
ted line width of the 13C creatine signals was more than 
50 Hz.
Creatine uptake
TCr amplitudes of individual muscles at days 0 till 5 were 
fitted to a linear function (Eq. 1) where TCr (t) is the 13C 
signal intensity at measurement day t. This was only calcu-
lated for the muscles that had at least 3 measurement days 
with spectra that passed the quality criteria (see above). 
The fitted slope gives the Cr uptake rate (kup) and the inter-
cept the initial TCr value (TCr0), both in arbitrary units 
(a.u.). The final uptake rate is presented as kup/TCr0 to give 
a value expressed in percentage per day. The error of the fit 
was treated as the standard deviation.
Creatine turnover
TCr signal intensities from day 5–105 were used to calcu-
late the turnover rate. Cr breakdown is assumed to follow 
first order kinetics (Walker 1979), so TCr signal intensi-
ties were fitted to a mono-exponential function (Eq. 2), 
under the assumptions described in (Kan et al. 2006). 
The maximal 13C TCr signal intensity is TCrmax, and kbr 
is the breakdown rate (% per day). The error of the fit was 
treated as the standard deviation. All curve fitting was 
done using Prism 5.0 (GraphPad Software, San Diego, 
CA, USA).
PCr/TCr ratio
The PCr/TCr ratio was determined per muscle over time 
for every measurement point unless the Cr and PCr signals 
could not be resolved properly (i.e., one or both signals 
fitted with amplitude 0). To compare the PCr/TCr ratios 
between individual muscles, the PCr/TCr ratios were aver-
aged over all these measurement points.










The Cr and PCr signal intensities were fitted as a function 
of the repetition time according to Eq. 3, giving a value for 
the T1 relaxation time in ms.
Statistics
A one-sided paired t test was used to compare blood plasma 
concentrations to day 0, and to assess differences between 
male and female muscles. Errors are given as standard 
deviation (SD) unless presented otherwise. Muscle specific 
effects of Cr uptake and PCr/TCr ratios were assessed by a 
one-way ANOVA. All statistical analysis were done using 
Prism 5.0 (GraphPad Software, San Diego, CA, USA), and 
statistical significance was set at p < 0.05.
Results
General observations
None of the subjects reported side effects of the cre-
atine supplementation. Blood analysis of the creatine 
content and 13C enrichment indicated that all subjects 
adhered to the prescribed intake of the supplementation 
(Table 2). At day 3, these values were comparable for 
young males and females, i.e., average Cr content was 
929 and 711 μM, respectively, and average 13C enrich-
ment 22 and 20 %, respectively. Two days after the 
supplementation period the plasma creatine levels had 
returned to normal values, but the 13C enrichment was 
still increased.
During the ingestion of 20 g/day 15 % enriched 13C-4–
Cr for 4 days, the 13C signals for PCr and Cr increased 
in muscles within the sensitive profile of the 13C/1H coil 
(Figs. 1, 2b). The separate signals of PCr and Cr were 
integrated by fitting, using the prior knowledge described 





Table 2  Plasma creatine concentrations and percentage 13C-4–Cr 
(mean ± SD)
Those at day 3 and day 7 are compared with day 0 by means of a one-
sided paired t test
** p < 0.01
Day 0 Day 3 Day 7
Plasma creatine (µM) 38 ± 23 668 ± 432** 41 ± 6
%13C 6.0 ± 0.6 19 ± 6.1** 10 ± 0.5**
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Creatine uptake rate
The summed intensities of the 13C signal of Cr and PCr 
determined at day 0 till day 5 were fitted to a linear function 
(Fig. 2c) to yield a subject and muscle specific Cr uptake 
rate. Following the spectral quality criteria, this analysis 
could be performed in 17 out of the 20 investigated mus-
cles of the young healthy volunteers. In males, a significant 
Cr uptake rate was observed in the SM, ST, and AM mus-
cles with less in the other two muscles (Fig. 3). In females, 
we could observe Cr uptake in all investigated muscles, 
except that the G muscle of one female was too thin to 
place a voxel solely in that muscle. The data of the BF and 
ST muscles of this female did not pass the quality criteria 
to obtain a Cr uptake rate mainly because of low signal-to-
noise ratio in some spectra. Taking all remaining muscles 
Fig. 2  13C MR spectra before, 
during and after creatine sup-
plementation in the ST muscle 
of a healthy young male subject. 
a Full 13C MR spectrum of this 
muscles at day 7, 3 days after 
the creatine supplementation 
period. Cr and PCr resonate at 
157.5 and 156.6 ppm, respec-
tively. Even though creatine is 
15 % 13C enriched the signal 
intensity is still much smaller 
than that of natural abundance 
13C lipid resonances. The inset 
shows the fit of the PCr and Cr 
resonances with the residual 
below. b Starting with day 0 a 
clear increase in signal intensity 
is observed during the 4 days 
of 13C-4–Cr supplementation 
followed by a slower decrease; 
the signal is still elevated up 
to day 108. c The uptake rate 
is fitted with a linear function 
over the first 5 days, and the 
breakdown rate was fitted by a 
mono-exponential decay. Note 
that for the uptake part, the 
integral of the creatine signals 
at day 0 is not included as the fit 
of these signals did not pass the 
quality criteria
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together the mean uptake rate in females was lower than in 
males although not significant (17 ± 26 vs. 36 ± 22 %/day 
with SD; p = 0.25).
To test the feasibility of the 13C MRSI assessment of 
muscular creatine uptake in more fragile persons, i.e., a 
82-year-old male and two FSHD patients, it was neces-
sary to decrease the number of exams during the supple-
mentation and thereafter. The creatine supplementation was 
well tolerated by all participants, and no side effects were 
reported.
The female FSHD patient (FSHD#1) showed fatty infil-
tration in the AM and SM muscles, and the male FSHD 
patient (FSHD#2) showed severe fatty infiltration in the 
SM muscle, and minor fatty infiltration in the ST and BF 
muscles. Following the spectral and fitting quality criteria, 
creatine uptake rates could be determined for FSHD#1 in 
the ST (48 ± 101 %/day), AM (27 ± 5 %/day), and the BF 
(9 ± 12 %/day), and for FSHD#2 in the BF (77 ± 184 %/
day). For the 82-year-old male, we observed Cr uptake 
in four of the five investigated muscles of which three 
passed the quality criteria. The SM had an uptake rate of 
8 ± 15 %/day, the BF 9 ± 28 %/day, and the G 24 ± 8 %/
day.
Creatine turnover
The Cr turnover was determined by fitting the TCr signal 
intensities from day 5–105 after start of supplementation, 
to a mono-exponential decay function (Fig. 2c). Because all 
Cr curves will fit to this function, even when no Cr uptake 
had taken place, we added a fit quality criterion that R2 has 
to be larger than 0.5 to ensure that the fitted values indeed 
follow a mono-exponential decay. Only data of three mus-
cles of male subject #2 and two muscles in the other male 
fulfilled this criterion. No turnover rates fulfilling the fit 
quality criteria could be determined for the female volun-
teers. For the muscles in which the Cr turnover could be 
determined, the rates were comparable with an average of 
2.1 ± 0.7 % per day (Fig. 4).
T1 relaxation times of 
13C‑4 spins
To verify that the pulse repetition time for MRSI acquisi-
tion did not cause signal saturation, we measured the T1 
relaxation times of the 13C spins in the hamstring muscle 
Fig. 3  Muscle specific creatine uptake rates (% per day) in four vol-
unteers: two young healthy males (YHM; black bars) and two young 
healthy females (YHF; gray bars), from left to right: semi-tendinosus 
(ST), semi-membranosus (SM), adductor magnus (AM), biceps fem-
oris (BF), and gracillis (G). Each uptake rate is the average of two 
muscles, except for the ST, BF, and G in YHF, for which the bars rep-
resent the uptake rate in one muscle. For the latter muscles, the error 
of the linear fit (see Fig. 2c) is given as SD. In the presented SD of 
the other muscles, these fitting errors have been considered
Fig. 4  Muscle specific Cr turnover rates (% per day) in young male 
volunteers. Only muscles in which the turnover signals were found to 
follow a mono-exponential decay were included. Turnover rate could 
not be determined if muscles showed relatively low Cr uptake. Bars 
indicate the mean uptake rate with standard error of the mean
Fig. 5  PCr/TCr ratios of the semi-tendinosus muscle before, during 
and after Cr supplementation of the four young healthy volunteers. 
PCr/TCr ratios were determined from 13C spectra acquired and ana-
lyzed as described in the materials and methods section. Bars indicate 
the mean values, and the error bars indicate the standard deviation
1863Monitoring creatine and phosphocreatine by 13C MR spectroscopic imaging during and after…
1 3
of one healthy young male subject by analyzing the 13C-4 
signals of Cr and PCr as a function of the repetition time. 
The T1 for Cr was 341 ± 36 ms and for PCr 413 ± 49 ms. 
This implies that with a 45° excitation pulse and a TR of 
1000 ms for the 13C MRSI acquisition, there will be little 
spin saturation.
PCr/TCr ratio
To investigate if creatine supplementation would change 
the PCr/TCr ratio, we determined this ratio for every time 
point during and after the supplementation. For none of 
the examined muscles in the healthy young volunteers, we 
observed a significant change in the PCr/TCr ratio during 
this period. An example is shown in Fig. 5 for this ratio in 
the ST muscle, which is around 0.75.
To investigate if the PCr/TCr ratio is the same as 
determined in other studies, we assessed this ratio for 
each investigated muscle in the young volunteers aver-
aged over all time points (Fig. 6a; Table 3). Testing each 
muscle against the other revealed that the PCr/TCr of the 
AM is significantly lower than that of the other muscles 
(p < 0.05), but a one-way ANOVA did not show a mus-
cle specific effect for the PCr/TCr ratio (p = 0.32). For 
all subjects and all muscles, together the average PCr/TCr 
ratio was 0.71 ± 0.07 (including a small correction for dif-
ferences in T1 between PCr and Cr).
The average PCr/TCr ratios of all investigated muscles 
in the old healthy male and FSHD patients were similar 
to the values of the young healthy subjects (see Fig. 6b), 
with T1-corrected values of 0.71 ± 0.03 and 0.71 ± 0.07, 
respectively.
Discussion
In this feasibility study, we demonstrate that 3D 13C MRS 
imaging with oral ingestion of 13C4–creatine can be used 
to monitor Cr uptake and turnover rates as well as PCr/TCr 
ratios in individual muscles of the human leg. Previously, 
we showed with unlocalized 13C MRS, and an RF coil next 
to the gastrocnemius of a male subject that the non-invasive 
monitoring of Cr and PCr during and after supplementation 
of 13C4-labeled Cr is feasible (Kan et al. 2006). Given the 
substantial variation in creatine uptake in different muscles, 
it is relevant to demonstrate that with 13C MRS in spectro-
scopic imaging mode, we can spatially resolve information 
of 13C labeled metabolites in multiple individual muscles in 
one exam. We applied this technique in a diverse group of 
subjects, including four young and one old healthy volun-
teer, and two patients with FSHD. In this way, the supplied 
Cr, and its immediate cellular product PCr, is assessed 
instead of the total Cr or PCr pool, as has been done with 
1H or 31P MRS after oral Cr ingestion, e.g., (Kreis et al. 
1999; Brault et al. 2007).
It is a common finding in human muscular studies of 
creatine uptake, assessed with biopsies, that TCr increases 
more than PCr during the supplementation period, e.g., 
(Hultman et al. 1996; McKenna et al. 1999). A study com-
bining 1H and 31P measurements to determine TCr and PCr 
Fig. 6  PCr/TCr ratios. a Muscle specific ratios in young healthy 
volunteers (n = 4). One-way ANOVA did not reveal statistical sig-
nificant muscle specific effect. Bars indicate the mean PCr/TCr per 
volunteer and the error bars indicate standard deviation. b Grouped 
data of the PCr/TCr ratio of the young healthy subjects, the FSHD 
patients, and the old volunteer. The PCr/TCr ratios of the FSHD and 
old subjects are within the range found in the young healthy subjects. 
YHmales/females young healthy subjects, FSHD FSHD patients, OH 
old healthy subject. Error bars indicate standard deviation
Table 3  Average muscular PCr/TCr ratios of the four young volun-
teers (mean ± SD)
With correction for the T1 values of Cr and PCr
Muscle Mean
ST 0.75 ± 0.04
SM 0.73 ± 0.03
AM 0.65 ± 0.03
BF 0.75 ± 0.07
G 0.70 ± 0.10
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in the vastus lateralis (where most biopsies are taken from) 
did not find this (Brault et al. 2007). The authors attribute 
this discrepancy to higher PCr hydrolysis during the biopsy 
procedure because of the change in physiological condition 
of muscles loaded with Cr. Our single subject study using 
13C MRS also did not find a change in the PCr/TCr ratio of 
the gastrocnemius during Cr uptake (Kan et al. 2006). In 
the present study, we assessed this for a few other muscles 
in the thigh and found no preferential increase in TCr over 
the supplementation period within the error of the measure-
ments. These findings indicate a general preservation of the 
overall thermodynamic equilibrium of the creatine kinase 
reaction in muscle cells at rest, also during Cr loading.
The range of average PCr/TCr ratios of the investigated 
muscles (from 0.65 to 0.75) is within the range reported 
in the literature for this ratio from 0.6 to 0.8 (Casey et al. 
1996; Mesa et al. 2002) and comparable with our previous 
unlocalized study of the gastrocnemius (Kan et al. 2006). 
The PCr/TCr ratio is similar for all the investigated muscles 
in the young volunteers with a somewhat lower value for 
the adductor magnus, which may be due to a different fiber 
type distribution (Johnson et al. 1973; Mesa et al. 2002).
Interestingly, the average PCr/TCr ratios in the older 
subject and FSHD patients were not different from the 
young volunteers indicating that energy balance and CK 
activity in the muscle of these subjects result in a similar 
thermodynamic equilibrium of the reaction at rest. In prin-
ciple, muscle specific PCr/TCr ratios can also be deter-
mined non-invasively with 1H and 31P MRS recordings of 
the same muscle, but this has not yet been reported as such.
The average muscular Cr turnover rate of 2.1 ± 0.7 % 
per day is in agreement with the results of our previous 
13C MRS study of a single subject and with the reported 
non-enzymatic breakdown rates of creatine to creatinine 
(Kan et al. 2006; Walker 1979; Wyss and Kaddurah-Daouk 
2000).
In particular, for muscles with relatively high SNR spec-
tra (SM and AM muscles of young volunteers), the data 
points indicate an apparent linear uptake of labeled Cr dur-
ing the 4 days supplementation. This is in agreement with 
previous supplementation studies and has been associated 
with near-saturation of the Cr transporters (Brault et al. 
2007), which would suggest that uptake rates reflect cre-
atine transporter capacity of muscles.
Cr uptake rates were variable among the five thigh mus-
cles and subjects and varied between 0 and about 80 % per 
day over all subjects and muscles. It is not possible that 
the lack of Cr uptake in some muscles is caused by sub-
jects not taking 13C-labeled Cr as the blood plasma samples 
analyzed before and during the Cr supplementation period 
showed similar increase in Cr and 13C-4–Cr concentration 
for all subjects during the supplementation period proving 
that they did ingest the provided 13C–Cr.
Differences in Cr response have been observed in rat 
hind limb muscles, with significant uptake in the gastroc-
nemius muscle but no response in the soleus muscle, an 
effect attributed to a higher contribution of type II fibers in 
the gastrocnemius (McMillen et al. 2001). In humans, the 
increases in (relative) Cr or PCr level after supplementation 
appear to differ among leg muscles with reported values 
from about 4 % for the gastrocnemius (Vandenberghe et al. 
1997) to about 20 % for quadriceps muscles (Kreis et al. 
1999; Smith et al. 1999). The origin of these differences is 
unknown; in studies addressing this issue, the proposed 13C 
MRSI method to assess uptake rates could be helpful.
Based on the reported values for Cr turnover rates, 
we estimate that to keep up with spontaneous constant 
Cr breakdown, a 13C signal increase in muscle spectra of 
10–30 %/day is expected during the supplementation. This 
implies that higher uptake rates are reflecting an increase of 
Cr levels in the muscles. It also suggests that for muscles 
with an uptake rate below about 10 %/day in this study, the 
SNR and/or the reproducibility of the measurement and/or 
fitting procedure of the Cr signal was inadequate.
For this 13C MRSI study, we increased the field strength 
from 1.5T to 3T and the 13C enrichment from 10 to 15 %, 
compared with our previous 13C MRS study (Kan et al. 
2006). The higher sensitivity allowed us to study 13C 
uptake and metabolism in individual muscles of young 
male subjects with sufficient SNR. However, this was less 
so in the females and older person and in FSHD patients, 
in which the quality filter only allowed to assess an uptake 
rate in four out of ten muscles. In the latter cases, this could 
be due to less Cr uptake or a lower muscular fraction. In a 
31P MRS study on FSHD patients, a preferential decrease 
of the SNR and the PCr/ATP ratio was observed in fat infil-
trated muscles (Kan et al. 2010). These results imply that 
for future clinical research studies with 13C MRSI, the SNR 
has to be improved, which can be achieved in several ways. 
First, the relative short T1 values of the 
13C spin systems in 
Cr and PCr (≈400 ms) at 3T allow for a shorter Tr than the 
currently used 1000 ms, so that more scans can be acquired 
in the same amount of time. Second, the voxel size can 
be enlarged in the length direction of the muscles. Third, 
improved MR instrumentation can be used, such as array 
RF coils or higher field strength, which requires substantial 
investments. Fourth, the 13C enrichment of the creatine can 
be increased, which, however, will increase the cost of the 
experiment. In addition, calibrations and registrations for 
better reproducibility, and signal fitting with more restric-
tive prior knowledge, such as line width limitations, may 
help.
For a full non-invasive investigation of muscular cre-
atine uptake, it would be important to also know the total 
amount of creatine during and after the supplementation 
(Nabuurs et al. 2013). As we already employ a proton RF 
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coil in the current setup, this can be most easily achieved 
by simultaneous or alternate 1H MRS measurements (Kreis 
et al. 1999).
In summary, we introduce an in vivo 13C MRS imag-
ing method to study intake and conversion of 13C labeled 
metabolites in skeletal muscles. We demonstrate that this 
allows for direct monitoring of supplied 13C4-labeled Cr 
for subject and muscle specific determination of PCr/TCr 
ratios, and Cr turnover and uptake rates.
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